» Articles » PMID: 30165047

MicroRNA 193a-5p Regulates Levels of Nucleolar- and Spindle-Associated Protein 1 to Suppress Hepatocarcinogenesis

Abstract

Background & Aims: We performed an integrated analysis to identify microRNAs (miRNAs) and messenger RNAs (mRNAs) with altered expression in liver tumors from 3 mouse models of hepatocellular carcinoma (HCC) and human tumor tissues.

Methods: We analyzed miRNA and mRNA expression profiles of liver tissues from mice with diethylnitrosamine-induced hepatocarcinogenesis, conditional expression of lymphotoxin alpha and lymphotoxin beta, or inducible expression of a Myc transgene (Tet-O-Myc mice), as well as male C57BL/6 mice (controls). miRNA mimics were expressed and miRNAs and mRNAs were knocked down in human (Huh7, Hep3B, JHH2) hepatoma cell lines; cells were analyzed for viability, proliferation, apoptosis, migration, and invasion. Cells were grown as xenograft tumors in nude mice and analyzed. We combined in silico target gene prediction with mRNA profiles from all 3 mouse models. We quantified miRNA levels in 146 fresh-frozen tissues from patients (125 HCCs, 17 matched nontumor tissues, and 4 liver samples from patients without cancer) and published human data sets and tested correlations with patient survival times using Kaplan-Meier curves and the log-rank test. Levels of NUSAP1 mRNA were quantified in 237 HCCs and 5 nontumor liver samples using the TaqMan assay.

Results: Levels of the miRNA 193a-5p (MIR193A-5p) were reduced in liver tumors from all 3 mouse tumor models and in human HCC samples, compared with nontumor liver tissues. Expression of a MIR193A-5p mimic in hepatoma cells reduced proliferation, survival, migration, and invasion and their growth as xenograft tumors in nude mice. We found nucleolar and spindle-associated protein 1 (NUSAP1) to be a target of MIR193A-5p; HCC cells and tissues with low levels of MIR193A-5p had increased expression of NUSAP1. Increased levels of NUSAP1 in HCC samples correlated with shorter survival times of patients. Knockdown of NUSAP1 in Huh7 cells reduced proliferation, survival, migration, and growth as xenograft tumors in nude mice. Hydrodynamic tail-vein injections of a small hairpin RNA against NUSAP1 reduced growth of Akt1-Myc-induced tumors in mice.

Conclusions: MIR193A-5p appears to prevent liver tumorigenesis by reducing levels of NUSAP1. Levels of MIR193A-5p are reduced in mouse and human HCC cells and tissues, leading to increased levels of NUSAP1, associated with shorter survival times of patients. Integrated analyses of miRNAs and mRNAs in tumors from mouse models can lead to identification of therapeutic targets in humans. The currently reported miRNA and mRNA profiling data have been submitted to the Gene Expression Omnibus (super-series accession number GSE102418).

Citing Articles

Gene targets with therapeutic potential in hepatocellular carcinoma.

Shodry S, Hasan Y, Ahdi I, Ulhaq Z World J Gastrointest Oncol. 2024; 16(12):4543-4547.

PMID: 39678796 PMC: 11577361. DOI: 10.4251/wjgo.v16.i12.4543.


MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities.

Mahboobnia K, Beveridge D, Yeoh G, Kabir T, Leedman P Int J Mol Sci. 2024; 25(17).

PMID: 39273339 PMC: 11395074. DOI: 10.3390/ijms25179393.


NUSAP1 promotes gastric cancer radioresistance by inhibiting ubiquitination of ANXA2 and is suppressed by miR-129-5p.

Ge Y, Wang B, Xiao J, Wu H, Shao Q J Cancer Res Clin Oncol. 2024; 150(8):406.

PMID: 39212774 PMC: 11364566. DOI: 10.1007/s00432-024-05927-8.


Immunotherapeutic value of NUSAP1 associated with bladder cancer through a comprehensive analysis of 33 human cancer cases.

Wen X, Hou J, Chu Y, Liao G, Wu G, Fang S Am J Cancer Res. 2024; 14(3):959-978.

PMID: 38590423 PMC: 10998758. DOI: 10.62347/BGAE1505.


Unveiling NUSAP1 as a common gene signature linking chronic HBV infection and HBV-related HCC.

Meng J, Yang Z, Jiang X, Zou J Discov Oncol. 2024; 15(1):61.

PMID: 38441732 PMC: 10914659. DOI: 10.1007/s12672-024-00922-4.


References
1.
Xie F, Hosany S, Zhong S, Jiang Y, Zhang F, Lin L . MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1. PLoS One. 2017; 12(10):e0185565. PMC: 5634539. DOI: 10.1371/journal.pone.0185565. View

2.
Haybaeck J, Zeller N, Wolf M, Weber A, Wagner U, Kurrer M . A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 2009; 16(4):295-308. PMC: 4422166. DOI: 10.1016/j.ccr.2009.08.021. View

3.
Kim S, Abou-Alfa G . The role of tyrosine kinase inhibitors in hepatocellular carcinoma. Clin Adv Hematol Oncol. 2014; 12(1):36-41. View

4.
Mak I, Evaniew N, Ghert M . Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014; 6(2):114-8. PMC: 3902221. View

5.
Heikenwalder M, Zeller N, Seeger H, Prinz M, Klohn P, Schwarz P . Chronic lymphocytic inflammation specifies the organ tropism of prions. Science. 2005; 307(5712):1107-10. DOI: 10.1126/science.1106460. View